TKTL1, transketolase like 1, 8277

N. diseases: 76; N. variants: 6
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.060 AlteredExpression phenotype BEFREE We used TKTL1 siRNA to observe the effect of reduced TKTL1 expression on gastric cancer tumorigenesis in a nude mice xenograft model and on proliferation in vitro. 20200485 2010
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.060 AlteredExpression phenotype BEFREE TKTL1 is activated by promoter hypomethylation and contributes to head and neck squamous cell carcinoma carcinogenesis through increased aerobic glycolysis and HIF1alpha stabilization. 20103683 2010
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.060 Biomarker phenotype BEFREE TKTL1 is reported to play a pivotal role in carcinogenesis and may have important implications in the nutrition and future treatment of patients with cancer. 19290028 2009
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.050 Biomarker phenotype BEFREE TKTL1 plays a major role in anaerobic glycolysis of tumor cells, leading to destruction of the basal membrane and metastasis as well as in controlling cell cycle. 31771043 2020
Malignant neoplasm of colon and/or rectum
0.050 Biomarker disease BEFREE We show that high TKTL1 in tumor tissue can lead to poor survival in colorectal cancer. 26650256 2016
Malignant neoplasm of colon and/or rectum
0.050 PosttranslationalModification disease BEFREE Subsequently, we screened four genes (ALOX15, GHRHR, TFPI2 and TKTL1) with aberrant methylation and aberrant hydroxymethylation at some genome position by functional enrichment analysis as candidate genes associated with colorectal cancer. 27546520 2016
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.050 AlteredExpression phenotype BEFREE No correlation was observed between cytoplasmatic or nuclear TKTL1 expression and tumor stage, grade or the presence of metastases. 25572961 2015
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.050 Biomarker phenotype BEFREE TKTL1 promotes cell proliferation and metastasis in esophageal squamous cell carcinoma. 26349965 2015
Malignant neoplasm of colon and/or rectum
0.050 AlteredExpression disease BEFREE Dysregulation of TKTL1 expression also leads to poor prognosis in patients with urothelial and colorectal cancer. 26349965 2015
Malignant neoplasm of colon and/or rectum
0.050 AlteredExpression disease BEFREE Hypoxia induces the expression of transketolase-like 1 in human colorectal cancer. 24193262 2013
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.050 AlteredExpression phenotype BEFREE To our knowledge, few studies have explored the association between variations in TKTL1 expression in the primary tumor and metastasis formation. 21980427 2011
Malignant neoplasm of colon and/or rectum
0.050 Biomarker disease BEFREE METHODOLODY/PRINCIPAL FINDINGS: Tumor tissues from 63 patients diagnosed with colorectal cancer at different stages of progression were analyzed for TKTL1 by immunohistochemistry. 21980427 2011
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.050 AlteredExpression phenotype BEFREE Significant differences in TKTL1 transcript levels were found between cases of PTC with and without LN metastases. 18615628 2008
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.040 Biomarker disease BEFREE After adjustment for other covariates, including statin therapy, this association was significant for both hand OA in men and women [OR 1.10(1.03-1.17), p < 0.01] (per unit standard deviation decrease in CRAE) and TKR prevalence [OR 1.15 (1.01-1.32), p = 0.04], especially for men [OR 1.22 (1.00-1.51) p = 0.04] and also for incident TKRs in men [OR 1.50 (1.07-2.10), p = 0.04]. 30671597 2019
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.040 Biomarker disease BEFREE Our study aimed to perform a molecular characterization of HER2-positive AGC and investigate the role of PI3K/Akt/mTOR signaling pathway activation and TKR gene copy number (GCN) gains as predictive biomarkers in HER2-positive AGC treated with trastuzumab. 29700210 2018
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.040 Biomarker disease BEFREE Baseline subject demographics, risk factors, KL score, cartilage WORMS score, presence of meniscus tear, and cartilage T<sub>2</sub> were used to predict the development of moderate/severe OA (KL = 3-4 or WOMAC pain ≥5 or total knee replacement [TKR]) over 8 years. 29143404 2018
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 Biomarker disease BEFREE Our study aimed to perform a molecular characterization of HER2-positive AGC and investigate the role of PI3K/Akt/mTOR signaling pathway activation and TKR gene copy number (GCN) gains as predictive biomarkers in HER2-positive AGC treated with trastuzumab. 29700210 2018
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.040 Biomarker disease BEFREE Preoperative and 6-month postoperative data on function (Short Form-36 Physical Component Summary [PCS] score), joint pain (Hip disability and Osteoarthritis Outcome Score and Knee injury and Osteoarthritis Outcome Score), and body mass index (BMI) were collected from a national sample of 2,040 patients who had undergone THR and 2,964 who had undergone TKR from May 2011 to March 2013. 28719557 2017
CUI: C0029408
Disease: Degenerative polyarthritis
Degenerative polyarthritis
0.040 Biomarker disease BEFREE Background and purpose - Little is know about patterns of sick leave in connection with total hip and knee joint replacement (THR and TKR) in patients with osteoarthritis (OA). 27996342 2017
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.040 AlteredExpression disease BEFREE This study investigated the expression of TKTL1 and p63 in gastric cancer and their clinical significance. 26406948 2015
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 AlteredExpression disease BEFREE This study investigated the expression of TKTL1 and p63 in gastric cancer and their clinical significance. 26406948 2015
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.040 AlteredExpression disease BEFREE We used TKTL1 siRNA to observe the effect of reduced TKTL1 expression on gastric cancer tumorigenesis in a nude mice xenograft model and on proliferation in vitro. 20200485 2010
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 AlteredExpression disease BEFREE We used TKTL1 siRNA to observe the effect of reduced TKTL1 expression on gastric cancer tumorigenesis in a nude mice xenograft model and on proliferation in vitro. 20200485 2010
CUI: C0024623
Disease: Malignant neoplasm of stomach
Malignant neoplasm of stomach
0.040 AlteredExpression disease BEFREE We propose that TKTL1 upregulation is a common phenomenon in GC and cancer of the GEJ leading to an enhanced, oxygen-independent glucose usage which might contribute to a more aggressive tumor growth. 16969476 2006
CUI: C0699791
Disease: Stomach Carcinoma
Stomach Carcinoma
0.040 AlteredExpression disease BEFREE We propose that TKTL1 upregulation is a common phenomenon in GC and cancer of the GEJ leading to an enhanced, oxygen-independent glucose usage which might contribute to a more aggressive tumor growth. 16969476 2006